摘要
目的探讨BiPAP无创呼吸机治疗AECOPD并Ⅱ型呼吸衰竭的临床疗效。方法方便选取该院2013年11月—2016年11月期间所收治的60例AECOPD并Ⅱ型呼吸衰竭患者应用BiPAP无创呼吸机治疗的临床效果进行回顾性分析,观察60例患者治疗前、治疗后4 h、治疗后72 h与治疗结束后pH、PaO_2、PaCO_2以及SaO_2等的变化,并观察患者的临床症状改善情况与不良反应发生情况。结果治疗后患者气促、心率快以及嗜睡等症状明显得到缓解,血压也无变化;60例患者中,有2例发生鼻梁损伤,3例鼻翼损伤,不良反应发生率为8.33%;患者治疗后4 h、治疗后72 h与治疗结束后与治疗前相比,差异有统计学意义。结论 BiPAP无创呼吸机治疗AECOPD并Ⅱ型呼吸衰竭的效果明显,能够有效改善患者的临床症状,改善患者血气指标,且不良反应少,值得应用。
Objective To investigate the clinical efficacy of BiPAP noninvasive ventilator in the treatment of AECOPD and type Ⅱ respiratory failure.Methods The clinical efficacy of BiPAP noninvasive ventilator was analyzed retrospectively from60 patients with AECOPD and type Ⅱ respiratory failure treated from November 2013 to November 2016.60 patients were treated before treatment and after treatment 4 hours,72 hours after treatment and pH,PaO_2,PaCO_2 and SaO_2 after treatment,and to observe the improvement of clinical symptoms and the occurrence of adverse reactions.Results After treatment,patients with shortness of breath,rapid heart rate and drowsiness and other symptoms were relieved,There was no change in blood pressure;60 patients,2 cases of nasal injury,3 cases of nasal injury,the incidence of adverse reactions was8.33%;4 hours after treatment,72 hours after treatment was a significant difference between the hour and the end of treatment and before treatment,which was statistically significant.Conclusion BiPAP noninvasive ventilator is effective in the treatment of AECOPD and type Ⅱ respiratory failure.It can effectively improve the clinical symptoms and improve the blood gas index of the patients,and the adverse reactions are less and worthy of application.
出处
《中外医疗》
2017年第13期62-63,66,共3页
China & Foreign Medical Treatment